Fluorouracil, Nivolumab, and Oxaliplatin

About

Membership operator: AND

Therapies: 3

Therapies

Fluorouracil (tx:ncit:C505)

Nivolumab (tx:ncit:C68814)

Oxaliplatin (tx:ncit:C1181)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
HC (1) PD-L1 >= 1% Esophageal Squamous Cell Carcinoma Fluorouracil, Nivolumab, Oxaliplatin